The WINFertility(SM) IVF Discount Treatment Program for Uninsured Infertility Patients Expands Texas Footprint to Houston

Share Article

Unique program that bundles IVF treatment AND medications, with discounts up to 40% for each IVF treatment cycle is now available to patients in Houston, Katy, Sugar Land and Webster, Texas.

The best possible IVF care at the best possible cost
The WINFertility approach is to promote high quality infertility care at the most competitive cost. Typical patient savings per IVF treatment cycle in Greater Houston range from $2,000 to $10,000 or more

WINFertility, Inc., the leader in Infertility Management Programs for insurers and employers, today announced the extension of its consumer offering to Greater Houston, its seventh major US market and its second in Texas. The expansion is designed to increase the availability of high quality, affordable IVF care that remains financially out of reach for many of the over quarter million Houstonians facing infertility today who are without advanced infertility insurance coverage.

Unlike any other solution in the market today, WINFertility simplifies, streamlines and discounts fertility treatments for uninsured patients seeking to have a baby. WINFertility developed one-of-a-kind evidence-based treatment protocols for IUI, IVF and Third Party Reproduction that are delivered by WINFertility's contracted, credentialed network of fertility specialists. Infertility medications are included in the single, discounted, bundled price for program participants. There are no age or medical criteria required to enroll in the program. If treatment is indicated by a participating provider and the patient has no infertility insurance coverage, or has exhausted their benefit, she can enroll in the WINFertility Program. Typical patient savings per IVF treatment cycle in Greater Houston range from $2,000 to $10,000 or more, depending on specific treatments and medication doses required.

Incorporated in the unique Consumer Program is access to WINFertility’s FertilityCoach Nurses(SM) on a 24/7 basis for education and care coordination, a Medical Advisory Board comprised of industry-leading Reproductive Endocrinologists and financing programs at preferred rates.

Program Available in Houston, Katy, Sugar Land and Webster
Effective today, the WINFertility Program is available in Houston exclusively through Fertility Specialists of Houston (FSH), one of the largest and most successful fertility practices in the state. Infertility patients in the region are treated at the four conveniently located offices. The fully accredited, state-of-the-art IVF laboratory at Houston Medical Center was developed to accommodate advanced fertility treatments and microsurgical procedures. The experienced team of fellowship-trained specialists at FSH provides a full range of infertility services, from female and male testing and diagnosis, through IUI, IVF, Donor Programs and pre-implantation genetic diagnosis (PGD). Fertility Preservation, Recurrent Pregnancy Loss and PCOS programs are also offered. “Since our inception in 1986, Fertility Specialists of Houston has catered to the whole patient, including the medical emotional and financial aspects of fertility treatment” said George Grunert, MD, founding partner of FSH. “Despite the many clinical advances and increased predictability of IVF, this uncertain economy presents another barrier for patients to conquer. By partnering with WINFertility, FSH patients have unique access to a discounted, bundled package that includes both IVF treatment and medications at a much more affordable price, so more people will be able to pursue their family-building dreams. We have always prided ourselves on being able to provide excellent clinical care and tremendous emotional support to our patients, now we can offer a financial program that is truly a value-added service.”    

More Access for More Patients
“Greater Houston is home to more than 6 million people. We are excited to be able to offer our unique program in such a large and dynamic marketplace, where so many struggle with the diagnosis of infertility and its associated expenses,” commented Tom Boyajy, COO of WINFertility. “The WINFertility approach is to promote high quality infertility care at the most competitive cost. The FSH team has long been recognized for both their compassionate, patient-centered approach and their excellent clinical results. Coupled with WINFertility’s proprietary treatment protocols, bundled packages, fertility management expertise, and considerable buying power, we are confident that Houstonians can now receive the very best IVF treatment value possible.”

“The response WINFertility has received about our Consumer Program continues to be very positive”, said Boyajy. “This encouraging reception is due to the compelling financial and clinical benefits of WINFertility’s offering that are distinct from other programs in every marketplace we have entered, most recently in Dallas. Texas is a very important market for us. As Houston is one of the largest and fastest-growing cities in the US, we are so pleased to have WINFertility participate in that growth and serve a broader patient population in the state."

About WINFertility
Founded in 2000, WINFertility is the national leader in Infertility Management Programs, annually managing infertility treatment for many thousands of infertility patients for major insurers and employers. WINFertility is leveraging their decade-long experience and clinical results in the fertility field, direct contracts with fellowship-trained fertility specialists, pharmaceutical manufacturers and national specialty pharmacies, to offer this unique direct-to-consumer program. Now, patients without infertility insurance coverage in Georgia, Florida, Illinois, Minnesota, New York and Texas can enroll in the WINFertility Program and take advantage of WIN’s integrated platform to access evidence-based protocols, quality providers and discounts enjoyed by the largest healthcare purchasers. For more information, visit us at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tom Boyajy, COO
Visit website